Siemens Healthineers AG (SMMNY)
| Market Cap | 51.95B -18.5% |
| Revenue (ttm) | 27.35B +2.8% |
| Net Income | 2.49B +6.8% |
| EPS | 2.22 +7.0% |
| Shares Out | n/a |
| PE Ratio | 20.88 |
| Forward PE | 16.62 |
| Dividend | 0.37 (1.57%) |
| Ex-Dividend Date | Feb 9, 2026 |
| Volume | 12,614 |
| Average Volume | 179,402 |
| Open | 23.41 |
| Previous Close | 23.55 |
| Day's Range | 22.98 - 23.41 |
| 52-Week Range | 22.77 - 29.00 |
| Beta | 0.82 |
| RSI | 34.18 |
| Earnings Date | May 7, 2026 |
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the readin... [Read more]
Financial Performance
In fiscal year 2025, Siemens Healthineers AG's revenue was 23.38 billion, an increase of 4.53% compared to the previous year's 22.36 billion. Earnings were 2.14 billion, an increase of 10.40%.
Financial numbers in EUR Financial StatementsNews
Dentsply Sirona: First-ever Dental Dedicated MRI System Validated In Trial, Cleared By FDA
(RTTNews) - Dentsply Sirona (XRAY) and Siemens Healthineers (SHL.DE) announced that the dental-dedicated ddMRI system - MAGNETOM Free.Max Dental Edition - has received FDA clearance. The companies sai...
Ki Reply and Data Reply Lay the Strategic Foundation for AI Innovation at Siemens Healthineers with “Cerebra”
TURIN, Italy--(BUSINESS WIRE)--Ki Reply and Data Reply, the Reply Group companies specialised respectively in AI-powered software development and data-driven solutions, have partnered with the “CRM Ex...
EQS-DD: Siemens Healthineers AG: Dorothea Simon, Purchase of Siemens Healthineers Shares in connection with Siemens Healthineers Share Programs: 1) Purchase in the amount of 200.00 EUR per month ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 17.02.2026 / 16:49 CET/CEST The issuer is solely responsi...
EQS-DD: Siemens Healthineers AG: Dorothea Simon, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 13.02.2026 / 14:59 CET/CEST The issuer is solely responsi...
Siemens Healthineers AG (SMMNY) Q1 2026 Earnings Call Transcript
Siemens Healthineers AG (SMMNY) Q1 2026 Earnings Call Transcript
Siemens Healthineers Core Businesses Offset Currency, Tariff Challenges
Revenue grew on a comparable basis as results in its imaging and precision therapy business units offset currency and tariff headwinds.
Siemens Healthineers beats Q1 profit estimates on strong imaging unit margins
Siemens Healthineers reported first-quarter operating profit above market expectations on Thursday, as strong margin performance in its core imaging and cancer-care units helped cushion a slump in its...
Siemens Healthineers: Potentially Much Stronger Than Siemens In 2026E
Siemens Healthineers (SEMHF) is undervalued, offering strong safety and upside, and remains a top 'BUY' pick for 2026. Key risks center on muted China growth, but ex-China performance is robust, with ...
5 European AI Stocks to Track in Q1 2026
While the artificial intelligence boom has continued to gather momentum in the United States and China, Europe's strengthening role in AI markets may be undervalued by investors, opening the door to f...
Siemens Healthineers AG (SMMNY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Siemens Healthineers AG (SMMNY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Siemens Healthineers AG (SMMNY) Analyst/Investor Day Transcript
Siemens Healthineers AG (OTCPK:SMMNY) Analyst/Investor Day November 17, 2025 8:00 AM EST Company Participants Bernhard Montag - President, CEO & Chairman of Management Board Jochen Schmitz - CFO & Mem...
Siemens Healthineers: Healthcare Remains Attractive After 2025
Siemens Healthineers remains a Buy, offering 15% annualized upside. Strong 2025 results, margin expansion, and resilient growth in Imaging and Varian segments support the investment case, despite Chin...
Siemens Healthineers preparing for potential Siemens's share sale -CFO
Siemens Healthineers is preparing for the possibility that its biggest shareholder Siemens AG may reduce its stake in the medical technology company to less than 50%, its CFO said on Wednesday.
Siemens Healthineers AG (SMMNY) Q4 2025 Press Conference Call Transcript
Siemens Healthineers AG (OTCPK:SMMNY) Q4 2025 Press Conference Call November 5, 2025 4:00 AM EST Company Participants Matthias Kraemer Bernhard Montag - President, CEO & Chairman of Management Board J...
Siemens Healthineers AG (SMMNY) Q4 2025 Earnings Call Transcript
Siemens Healthineers AG (OTCPK:SMMNY) Q4 2025 Earnings Call November 5, 2025 2:00 AM EST Company Participants Marc Koebernick - Head of Investor Relations Bernhard Montag - President, CEO & Chairman o...
Siemens Healthineers Reports Fall in Profits, Citing Tariffs
Higher comparable revenue stemming from the transformation program of its diagnostics business was offset by a hit from U.S. tariffs.
Siemens Healthineers slightly misses sales expectations in fourth quarter
Siemens Healthineers on Wednesday reported fourth-quarter revenue slightly below analysts' consensus as higher U.S. import tariffs weigh.
New Drug Testing Analyzer from Siemens Healthineers Raises the Bar for Court, Military, and Forensics Testing, Offering Clinical-Quality Results
TARRYTOWN, N.Y.--(BUSINESS WIRE)-- #drugtesting--New drug testing analyzer helps identify substance use, monitor therapeutic and immunosuppressant drugs, and perform serum toxicology testing.
Siemens Healthineers AG - Special Call
Siemens Healthineers AG - Special Call Company Participants Presentation Unknown Executive Welcome to our pre-close catch-up for Q4 fiscal year 2025, which was recorded on September 25, 2025. In this ...
VedaBio Announces Strategic Agreement with Siemens Healthineers and Series A Extension, Totaling Up to $25 Million
SAN DIEGO--(BUSINESS WIRE)--VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a Series A extension alongside a strategic agreement with Siemens Healthineers...
EVIDENT and Siemens Healthineers Join Efforts to Advance Digital Pathology at Klinikum Ludwigshafen
Collaboration combines AI imaging, diagnostics expertise, and clinical leadership to drive digital pathology forward Collaboration combines AI imaging, diagnostics expertise, and clinical leadership t...
Carna Health and Siemens Healthineers join forces to Advance Kidney Care Innovation
BOSTON--(BUSINESS WIRE)--Carna Health, a digital health company revolutionizing kidney care, announced a strategic agreement with Siemens Healthineers to accelerate adoption of Carna's AI-enabled chro...
Siemens reduces stake in Siemens Healthineers to 71.12%
Siemens AG reduced its stake in medical technology company Siemens Healthineers by nearly 2 percentage points to 71.12%, according to a regulatory filing.
Siemens Healthineers AG (SEMHF) Q3 2025 Earnings Call Transcript
Siemens Healthineers AG (OTCPK:SEMHF) Q3 2025 Earnings Conference Call July 30, 2025 2:30 AM ET Company Participants Bernhard Montag - President, CEO & Chairman of Management Board Jochen Schmitz - CF...
Siemens Healthineers meets Q3 sales expectations, raises guidance
German medical technology company Siemens Healthineers on Wednesday reported third-quarter revenue slightly above analysts' consensus, citing strong growth in its China business after declines last ye...